Inherited deficiencies of the enzymes adenosine deaminase (adenosine aminohydrolase; EC 3.5.4.4) and purine nucleoside phosphorylase (purine-nucleoside:orthophosphate ribosyltransferase; EC 2.4.2.1) preferentially interfere with lymphocyte development while sparing most other organ systems. Previous experiments have shown that through the action of specific kinases, nucleosides can be "trapped" intracellularly in the form of 5'-phosphates. We therefore measured the ability of newborn human tissues to phosphorylate adenosine and deoxyadenosine, the substrate of adenosine deaminase, and also inosine, deoxyinosine, guanosine, and deoxyguanosine, the substrates of purine nucleoside phosphorylase. Substantial activities of adenosine kinase were found in all tissues studied, while guanosine and inosine kinases were detected in none. However, the ability to phosphorylate deoxyadenosine, deoxyinosine, and deoxyguanosine was largely confined to lymphocytes. Adenosine deaminase, but not purine nucleoside phosphorylase, showed a similar lymphoid predominance. Other experiments showed that deoxyadenosine, deoxyinosine, and deoxyguanosine were toxic to human lymphoid cells. The toxicity of deoxyadenosine was reversed by the addition of deoxycytidine, but not uridine, to the culture medium. Based upon these and other experiments, we propose that in adenosine deaminase and purine nucleoside phosphorylase deficiency, toxic deoxyribonucleosides produced by many tissues are selectively trapped in lymphocytes by phosphorylating enzyme(s).
while guanosine and inosine kinases were detected in none. However, the ability to phosphorylate deoxyadenosine, deoxyinosine, and deoxyguanosine was largely confined to lymphocytes. Adenosine deaminase, but not purine nucleoside phosphorylase, showed a similar lymphoid predominance. Other experiments showed that deoxyadenosine, deoxyinosine, and deoxyguanosine were toxic to human lymphoid cells. The toxicity of deoxyadenosine was reversed by the addition of deoxycytidine, but not uridine, to the culture medium. Based upon these and other experiments, we propose that in adenosine deaminase and purine nucleoside phosphorylase deficiency, toxic deoxyribonucleosides produced by many tissues are selectively trapped in lymphocytes by phosphorylating enzyme(s).
During the past 5 years, Giblett and her colleagues have demonstrated an association between severe deficiencies of either adenosine deaminase (adenosine aminohydrolase; EC 3.5.4.4), or purine nucleoside phosphorylase (purine-nucleoside:orthophosphate ribosyltransferase; EC 2.4.2.1) and inherited forms of human immunodeficiency disease (1, 2) . Although the clinical pictures overlap, children with adenosine deaminase deficiency usually suffer from a combined immunodeficiency syndrome, with impairment of T cell development and in most cases of B cell function as well, while those with purine nucleoside phosphorylase deficiency have primarily a deficit in T cell development and the associated cellular immune functions.
Both diseases are accompanied by severe lymphopenia. Although enzyme is virtually absent from all tissues examined, apparently only the growth and development of the lymphoid system is severely retarded (3) . It (5) , hypoxanthine deficiency (6), and adenosine-mediated elevations in cyclic AMP concentrations (7) . In the absence of further information, these hypotheses do not explain the preferential impairment of lymphoid development seen in both phosphorylase and deaminase deficiency. In the present studies, we suggest that lymphospecific toxicity in deaminase and phosphorylase deficiency may result from the selective accumulation in lymphoid tissues, particularly the thymus, of toxic deoxyribonucleotides, mediated by nucleoside kinase(s).
MATERIALS AND METHODS
Tissue Extracts. Newborn human tissues obtained at autopsy within 24 hr of death were frozen at -20°. Extracts were prepared by mincing the specimens in 10 mM Tris buffer (pH 7.4), followed by five cycles of freeze-thawing, and ultracentrifugation of the particulate material.
Peripheral blood lymphocytes and granulocytes were isolated by dextran sedimentation of heparinized whole blood from an adult volunteer, followed by centrifugation through FicollHypaque (8) . Red cells were lysed with Tris-buffered ammonium chloride and the cells were washed and frozen (9) .
The protein content of all tissue extracts was determined by Lowry's method, with bovine serum albumin as a standard (10) .
Enzyme Assays. Kinase activities in cell extracts and column fractions were determined by a modification of the method of Ives et al. (11) . For the measurement of deoxyguanosine, guanosine, deoxyinosine, and inosine kinases, the final concentrations of the reactants were: 50 mM Tris (final pH 7.4), 10 mM ATP, 10 mM MgCI2, 15 mM NaF, 1 mg of protein per ml, and 0.4-2 ,uCi of substrate at a concentration of 300 ,M in a total volume of 100 X. Adenosine and deoxyadenosine kinases were similarly measured, except that the ATP and magnesium concentrations were 5 and 2.5 mM, respectively. In addition, to each sample was added the deaminase inhibitor erythro-9-(2-hydroxy-3-nonyl)adenine hydrochloride (EHNA) to a final concentration of 5 ,M.
The reactions were initiated by the addition of labeled substrate. After 30 min at 370 in a shaking water bath, the samples Abbreviations: deaminase, adenosine deaminase; phosphorylase, purine nucleoside phosphorylase; EHNA, erythro-9-(2 hydroxy-3-nonyl)-adenine hydrochloride. Human tissues were obtained from two babies (I and II) who died during parturition, while peripheral lymphocytes and granulocytes were isolated from the blood of a normal adult. Activities are expressed as nmol of product per min/mg of protein at a substrate concentration of 300 PM. NA, not available for study. were boiled for 2 min and insoluble material was centrifuged at 4°. Control experiments with [14C]inosine monophosphate showed no nucleotide breakdown under these conditions.
Nucleotides were separated from the nucleosides and bases by chromatography on PEI-cellulose thin-layer plates (E. Merck, Darmstadt) affixed with a paper wick and developed overnight in methanol/water (1:1) (12). In representative experiments the nucleotides that remained at the origin were further fractionated into the mono-, di-, and triphosphates by a second development in sodium formate (pH 3.4) (13) or by two-dimensional chromatography with a discontinuous buffer system (14) .
When tritiated isotopes were used, the nucleotide spots were cut out and extracted with 1 ml of 1 M TrisIHCl/0.7 M MgCl2 at pH 7.4 before the addition of scintillation fluid (11) . When 14C isotopes were used, extraction of the product was unrtecessary.
Deaminase and phosphorylase activities were also determined radiochemically, as previously described (8, 15) .
Ion-Exchange Chromatography. Twenty milligrams of thymic cell extracts was dialyzed against 5 mM sodium phosphate (pH 7.9) and applied to a 1-ml column of DE52-cellulose (Whatman Ltd., Maidstone, Kent) equilibrated at 40 with the same buffer. After unbound material was washed with the above buffer, the column was eluted with a linear gradient made from 6 ml of the above buffer and 6 ml of the same buffer with 0.3 M NaCl. One-milliliter fractions were collected and assayed for enzymatic activity as described above.
Lymphocyte Growth Studies. Normal human peripheral blood lymphocytes were cultured as described in RPMI 1640 medium supplemented with 2 mM glutamine, 10% heat-inactivated human AB Rh-positive serum, and 10 ,tg of phytohemagglutinin-M per ml (DIFCO, Detroit, MI) as well as various nucleosides (8) . After 3 days, blastogenesis was measured by the linear uptake of tritiated leucine into protein over a 4-hr period. Thymidine uptake was not measured, insofar as previous experiments showed that nucleosides can increase or decrease thymidine uptake independent of any effects on growth (8) .
A clone (Cl-35) of the human lymphoblastoid cell line WIL-2, deficient in hypoxanthine phosphoribosyltransferase (EC 2.4.2.8), was selected as described and grown in minimum essential medium with 10% dialyzed fetal calf serum (16 Lymphocyte Growth Studies. The addition of deoxyadenosine to peripheral lymphocyte cultures depressed their response to phytohemagglutinin (Fig. 2) . The toxicity of deoxyadenosine was potentiated 1000-fold by inhibition of deaminase with EHNA.
Not having a potent phosphorylase inhibitor or a phosphorylase-deficient cell line, we could not study in isolation the effects of deoxyguanosine and deoxyinosine on human lymphocytes. However, the growth of the hypoxanthine phosphoribosyltransferase-deficient human lymphoblastoid cell line C1-35, although unaffected by either guanosine or inosine, was inhibited by deoxyguanosine and deoxyinosine (Table 2 ). Other studies showed that this cell line, as expected, had the ability to phosphorylate the purine deoxvribonucleosides but not the ribonucleosides guanosine or inosine.
The toxicity of deoxyadenosine alone or deoxyadenosine plus EHNA toward phytohemagglutinin-stimulated lymphocytes was reversed by the addition of deoxycytidine but not uridine to the culture medium (Table 3) , consistent with previous experiments by Reichard et al. (18) and Klenow (19) . The inhibitory effects of deoxyguanosine and deoxyinosine on the growth of human lymphoblastoid cell lines, however, were not reversed by deoxycytidine.
DISCUSSION
In the studies reported here, we have tried to explain not the detailed biochemical mechanisms by which deficiencies of adenosine deaminase and purine nucleoside phosphorylase produce immunodeficiency, but rather why both defects might preferentially impair lymphocyte function. Patterson has summarized evidence which suggests that purines may be exchanged between cells and tissues at the nucleoside level, via a process of facilitated diffusion (20 (14, 21, 22) .
There is no good evidence that deaminase functions normally as a major pathway in the production of uric acid. In support of this interpretation, deaminase-deficient children have normal uric acid levels in plasma and urine (23) .
The ability to phosphorylate and trap deoxyadenosine, unlike adenosine, is largely confined to lymphoid tissues, whether or not they are actively dividing, as is the newborn thymus, or are in a quiescent state, as is the adult peripheral blood lymphocyte. Cells were grown in minimum essential medium with 10% dialyzed fetal calf serum. Nucleosides at the concentrations indicated were added at time zero. Comparable concentrations of hypoxanthine or 0.1 mM guanine had no effect on cell growth (32 5 + 1 * Human peripheral blood lymphocytes were stimulated with phytohemagglutinin in the presence or absence of the indicated nucleosides. After 3 days the percent control leucine uptake into acid-precipitable material was determined as described in the legend ot Fig. 2 . Six cultures were examined in all cases. t P values compare the means of the cultures with uridine or deoxycytidine with those containing deoxyadenosine alone by Students' t test.
NS, not significant.
However, the Km of 400 gAM for deoxyadenosine phosphorylation far exceeds the reported Km of 7 AiM for deamination (22) .
Hence, when deaminase is present, deoxyadenosine is likely to be deaminated rather than phosphorylated at low substrate concentrations. A low rate of conversion of deoxyadenosine to adenine ribonucleotides has also been reported (14) . That the tissue distribution of deaminase in general parallels that of deoxyadenosine kinase may indicate a role for deaminase in the prevention of deoxyadenosine phosphorylation. In deaminase deficiency, on the other hand, deoxyadenosine may be excreted by many tissues impaired in their ability to deaminate or phosphorylate the nucleoside, only to become trapped in lymphoid tissues in spite of a low plasma concentration. Polmar et al. have reported a 10-fold increase in ATP content of peripheral lymphocytes from a deaminase-deficient patient as compared to those of normal controls, and that transfusion of frozen irradiated erythrocytes decreased ATP concentrations (4) . This result conflicts with our hypothesis, which would not predict the selective accumulation of adenine ribonucleotides by lymphocytes. However, the enzymatic methods used by Polmar et al. would not distinguish ATP from dATP. It is therefore possible that, in fact, deoxyadenosine nucleotides and not adenine ribonucleotides are elevated in deaminase-deficient lymphocytes. Further investigations with more specific methods should resolve this question.
Patients with phosphorylase deficiency show elevated concentrations of inosine, deoxyinosine, guanosine, and deoxyguanosine in their plasma and urine, thus providing further evidence for the absence of guanosine kinase or inosine kinase activity in human tissues (24) . Consequently, phosphorylase (and hypoxanthine phosphoribosyltransferase), may well be required for the normal recycling of inosine and guanosine, a fact that is reflected in the necessarily widespread tissue distribution of phosphorylase and the reported overproduction of purines by phosphorylase-deficient patients (24) .
Deoxyguanosine and deoxyinosine, unlike their ribonucleoside analogues, can be directly phosphorylated and trapped by lymphocytes enriched in the appropriate kinase. As was true for deoxyadenosine, here too the K111 of 400,M for phosphorylation compared to approximately 50 ,uM for phosphorolysis (25) suggests that at physiologic substrate concentrations phosphorylation is unlikely to be significant. In phosphorylase deficiency on the other hand, deoxyguanosine and deoxyinosine should be taken up by lymphocytes at an increased rate as well as excreted into the urine unchanged.
Durham and Ives have previously shown that the murine enzyme deoxycytidine kinase is confined to lymphoid tissues, especially the thymus (26) . These authors subsequently purified the calf thymus enzyme and showed that it could also phosphorylate deoxyadenosine and deoxyguanosine (27) . Krygier and Momparler, on the other hand, purified an activity from calf thymus that phosphorylated deoxyadenosine and deoxyguanosine but not deoxycytidine (28) . Recently, Krenitsky et al. have studied in detail the substrate specificity of a partially purified calf deoxycvtidine kinase that could phosphorylate deoxyadenosine, deoxyinosine, and deoxyguanosine as well as many synthetic substrates (29) . Not yet having purified the human enzyme to homogeneity, we cannot conclusively determine its substrate specificity. However, in preliminary experiments we found that human deoxycytidine phosphorylating activity cochromatographed on DE52-cellulose with deoxyadenosine kinase.
The mechanisms by which trapped deoxyribonucleotides might inhibit lymphocyte growth are unclear. Under certain conditions deoxyribonucleotide triphosphates can be inhibitors of ribonucleotide reductase (30, 31) . Our studies showed that deoxyadenosine and deoxyguanosine were indeed converted by lymphocyte extracts to the respective triphosphates. However, deoxyinosine, which was converted only to the monophosphate form, still inhibited cell growth, albeit at higher concentrations than did deoxyguanosine.
Before enzyme replacement in the form of erthyrocyte transfusion was used, the immunodeficient state associated with deaminase deficiency had been successfully treated with bone marrow or fetal liver transplantation (4, 33) . When these preferential methods fail or are unavailable, an attempt might be made to modify the disease state at the molecular and cellular level. As 
